Results 191 to 200 of about 798,328 (346)

Machine Learning‐Enabled Polymer Discovery for Enhanced Pulmonary siRNA Delivery

Advanced Functional Materials, EarlyView.
This study provides an efficient approach to train a machine learning model by merging heterogeneous literature data to predict suitable polymers for siRNA delivery. Without the need for extensive laboratory synthesis, the machine learning enabled a virtual screening and successfully predicted a polymer that is validated for effective gene silencing in
Felix Sieber‐Schäfer, Min Jiang, Adrian Kromer, Anny Nguyen, Müge Molbay, Simone Pinto Carneiro, David Jürgens, Gerald Burgstaller, Bastian Popper, Benjamin Winkeljann, Olivia Monika Merkel   +10 more
wiley   +1 more source

Artificial intelligence in clinical pharmacy-A systematic review of current scenario and future perspectives. [PDF]

Digit Health
Alqahtani SS, Menachery SJ, Alshahrani A, Albalkhi B, Alshayban D, Iqbal MZ.   +5 more
europepmc   +1 more source

Embedded 3D‐Coaxial Bioprinting of Stenotic Brain Vessels with a Mechanically Enhanced Extracellular Matrix Bioink for Investigating Hemodynamic Force‐Induced Endothelial Responses

Advanced Functional Materials, EarlyView.
In this study, a physically enhanced vascular dECM bioink and used 3D‐coaxial bioprinting are developed to fabricate mature brain blood vessels for cerebral atherosclerosis research. This model demonstrates that vascular geometry‐induced hemodynamic changes trigger vascular inflammation, ensuring its potential for cerebrovascular research.
Wonbin Park, Min‐Ju Choi, Jae‐Seong Lee, Minjun Ahn, Wonil Han, Ge Gao, Dong‐Woo Cho, Byoung Soo Kim   +7 more
wiley   +1 more source

Practice Guidelines for the Value Evaluation of Clinical Pharmacy Services (version 2). [PDF]

Front Public Health
Wu L, Lv Z, Chen M, Zheng X, Li L, Du S, Han L, Yin Q, Wang Y, Liu X, Li W, Huang X, Wang H, Yi X, Cui X, Chen Z, Wang Y, Hou Y, Zheng X, Lei Y, Gou M, Wu Y, Kang F, Cai F, Liang S, Yang Y, Li J, Bian Y.   +27 more
europepmc   +1 more source

IMPACT OF DIRECT PATIENT CARE CLINICAL PHARMACY SERVICES ON RENAL TRANSPLANT PATIENT SATISFACTION WITH HEALTH CARE QUALITY.

, 2000
Marie A. Chisholm, Leslie J. Vollenweider, Laura L. Mulloy, J. D. Wynn, Muralidharan Jagadeesan, Joseph T. DiPiro   +5 more
openalex   +1 more source

A systemic methodology for risk management in healthcare sector [PDF]

, 2011
Anna Corinna Cagliano, Apkon, Armitage, Barach, Bartlett, Baysari, Baysari, Bridges, Brown, Burgmeier, Carlo Rafele, Cohen, Cosby, Damelio, Davis, Embrey, Embrey, Garthwaite, Graham, Gray, Harms-Ringdahl, Harvard Business School, Hillson, Hillson, Hollnagel, Hollnagel, Janssen, Johansson, Körvers, Leape, Liker, Liker, Linch, Lucas, Lyons, Lyons, McDonald, McNally, Norman, Ohno, Ookalkar, O’Hagan, Paz Barroso, Project Management Institute, Project Management Institute, Reason, Reason, Ross Baker, Roth, Sabrina Grimaldi, Saizy-Callaert, Sale, Stalhandske, Thomas, Tonneau, Vincent, Vincent, Vincent, Vissers, Wiegmann, Wieman, Wilson, Zidel   +62 more
core   +1 more source

Endocytic Programming via Porous Silicon Nanoparticles Enhances TLR4 Nanoagonist Potency for Macrophage‐Mediated Immunotherapy

Advanced Functional Materials, EarlyView.
Porous silicon nanoparticles (PSiNPs) reprogram macrophage endocytosis of manganese@albumin‐based TLR4 nanoagonists, driving TRIF‐biased TLR4 signaling, eliciting robust proinflammatory responses, and potentiating macrophage‐mediated immunotherapeutic effects against NSCLC.
Xiaomei Zhang, Huiying Li, Shuodan Huang, Linxuan Zhang, Yan Gao, Ruoran Wang, Xiaoyu Wang, Hélder A. Santos, Zhenyu Yin, Bing Xia   +9 more
wiley   +1 more source

Integrating Clinical Pharmacy Services Into Comprehensive Multiple Sclerosis Care Teams: A Narrative Review of 4 Models. [PDF]

Int J MS Care
Bozinov N, Ramsrud A, Montgomery JH, Merrill S, Rajkovic SN, Nair KV.   +5 more
europepmc   +1 more source

Pharmaceutical Care by Clinical Pharmacy Service of the Pharmacist in the Palliative Care Unit. Survey for Improving the Flavoring of Morphine Oral Solution.

, 2000
KENICHI KONISHI, MASAKO SEKIMOTO, Hirofumi Abo, TIZURU KUBOYAMA, KAZUHARU INOKUMA, Reiko Teraoka, Yoshihisa Matsuda   +6 more
openalex   +2 more sources

Cholesterol in mRNA‐Lipid Nanoparticles can be Replaced with the Synthetic Mycobacterial Monomycoloyl Glycerol Analogue MMG‐1

Advanced Functional Materials, EarlyView.
This study demonstrates that cholesterol in messenger RNA‐lipid nanoparticles (mRNA‐LNPs) can be completely replaced with an immunopotentiating lipid, i.e., a synthetic analogue of the C‐type lectin receptor agonist monomycoloyl glycerol (MMG‐1), without compromising physicochemical properties, in vivo transfection efficiency, and immunogenicity of the
Abhijeet G. Lokras, Saahil S. Baghel, Rune F. Jensen, Aneesh Thakur, Henrik Franzyk, Oskar Thofte, Marco Herrera‐Barrera, Madeleine Landry, Melike Ongun, Ahmad Tami, Marlene P. Thanthrige, Eva Callens, Corinne Beinat, Thomas Rades, Søren R. Paludan, Kristian Riesbeck, Ida Rosenkrands, Dennis Christensen, Gabriel K. Pedersen, Camilla Foged   +19 more
wiley   +1 more source